Back
Regulus Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
35
RGLS
Regulus Therapeutics
Last Price:
$1.54
Seasonality Move:
7.82%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing slight buying pressure.
Regulus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.57 | Buy |
| 20-day SMA: | 1.59 | Buy |
| 50-day SMA: | 1.53 | Buy |
| 200-day SMA: | 1.89 | Sell |
| 8-day EMA: | 1.57 | Buy |
| 20-day EMA: | 1.57 | Buy |
| 50-day EMA: | 1.56 | Buy |
| 200-day EMA: | 1.67 | Sell |
Regulus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.82 | Buy |
| Chaikin Money Flow: | 196737 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Regulus Therapeutics Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regulus Therapeutics Stock
Is Regulus Therapeutics Stock a Buy?
-
Regulus Therapeutics share price is 1.60 while RGLS 8-day simple moving average is 1.57, which is a Buy signal.
-
The stock price of RGLS is 1.60 while Regulus Therapeutics 20-day SMA is 1.59, which makes it a Buy.
-
Regulus Therapeutics 50-day simple moving average is 1.53 while RGLS share price is 1.60, making it a Buy technically.
-
RGLS stock price is 1.60 and Regulus Therapeutics 200-day simple moving average is 1.89, creating a Sell signal.
RGLS Technical Analysis vs Fundamental Analysis
Sell
35
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy or a Sell?
-
Regulus Therapeutics stock is rated a SellThe current Regulus Therapeutics [RGLS] share price is $1.60. The Score for RGLS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Regulus Therapeutics Stock Info
Market Cap:
104.8M
Price in USD:
1.60
Share Volume:
196.7K
Regulus Therapeutics 52-Week Range
52-Week High:
3.79
52-Week Low:
1.08
Sell
35
Regulus Therapeutics (RGLS)
is a Sell
Regulus Therapeutics Share Price Forecast
-
What is the Regulus Therapeutics stock price today?The Regulus Therapeutics stock price is 1.60 USD today.
-
Will RGLS stock go up or go down?Regulus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Regulus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regulus Therapeutics is overvalued.
Is Regulus Therapeutics Stock a Buy?
-
Regulus Therapeutics share price is 1.60 while RGLS 8-day exponential moving average is 1.57, which is a Buy signal.
-
The stock price of RGLS is 1.60 while Regulus Therapeutics 20-day EMA is 1.57, which makes it a Buy.
-
Regulus Therapeutics 50-day exponential moving average is 1.56 while RGLS share price is 1.60, making it a Buy technically.
-
RGLS stock price is 1.60 and Regulus Therapeutics 200-day simple moving average is 1.67, creating a Sell signal.
Fundamental Analysis of Regulus Therapeutics
Is Regulus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Regulus Therapeutics
Should I short Regulus Therapeutics stock?
-
RGLS Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Regulus Therapeutics is a Buy
-
Regulus Therapeutics Relative Strength Index (RSI) is 52.82, which suggest Regulus Therapeutics is overbought
-
The Bollinger Bands (25) for Regulus Therapeutics is ( - ), which suggest Regulus Therapeutics is a Buy
-
The Bollinger Bands (100) for Regulus Therapeutics is ( - ), which suggest Regulus Therapeutics is a Buy
* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.